FDA Device Intelligence
Home › Integra Lifesciences Corporation › Integra® Dermal Regeneration Template

Integra® Dermal Regeneration Template

Integra Lifesciences Corporation · Model 38105 · UDI-DI 10381780000617

MGRMDD Prescription
0
510(k) clearances
220
Adverse events (55 deaths)
7
Recalls
6
Facilities

Description

INTEGRA Dermal Regeneration Template 8in. x 10in. (20cm x 25cm) is a bilayer membrane system for skin replacement. The dermal replacement layer is made of a porous matrix of fibers of cross-linked bovine tendon collagen and a glycosaminoglycan (chondroitin-6-sulfate) that is manufactured with a controlled porosity and defined degradation rate. The epidermal substitute layer is made of a thin polysiloxane (silicone) layer to control moisture loss from the wound.

Recalls

DateFirmReason
2011-02-21Organogenesis, Inc.Product sterility may be compromised
2011-01-30Organogenesis, Inc.Product sterility compromised
2010-08-02Organogenesis, Inc.Product is contaminated with a yeast identified as Pseudozyma antarctica.
2009-09-27Organogenesis, Inc.Unit contaminated with Staphylococcus epidermidis
2007-12-26Organogenesis, Inc.Contamination: Apligraf units were reported to have contamination in the agarose nutrient medium of some units retained at Organogenesis. Preliminary tests show a gram negative r
2006-09-29Organogenesis, Inc.Product pH out of specification
2003-05-02Smith and Nephew Wound Management (La Jolla)Did not meet finished device specifications for the DNA criteria.

Query this across every FDA database — by API.

Linked GUDID · 510(k)/PMA · MAUDE · recalls · establishments. Free tier, no card required.

Get your free API keyRead the docs
Data compiled from public U.S. FDA sources (GUDID, 510(k)/PMA, MAUDE, recalls, establishment registration). Adverse-event reports are unverified and do not establish causation. Informational only — not medical, clinical, or regulatory advice.